Cargando…
Genetic Ablation of LAT1 Inhibits Growth of Liver Cancer Cells and Downregulates mTORC1 Signaling
Through a comprehensive analysis of the gene expression and dependency in HCC patients and cell lines, LAT1 was identified as the top amino acid transporter candidate supporting HCC tumorigenesis. To assess the suitability of LAT1 as a HCC therapeutic target, we used CRISPR/Cas9 to knockout (KO) LAT...
Autores principales: | Kim, Sun-Yee, Ong, Qunxiang, Liao, Yilie, Ding, Zhaobing, Tan, Alicia Qian Ler, Lim, Ler Ting Rachel, Tan, Hui Min, Lim, Siew Lan, Lee, Qian Yi, Han, Weiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253063/ https://www.ncbi.nlm.nih.gov/pubmed/37298123 http://dx.doi.org/10.3390/ijms24119171 |
Ejemplares similares
-
LATS suppresses mTORC1 activity to directly coordinate Hippo and mTORC1 pathways in growth control
por: Gan, Wenjian, et al.
Publicado: (2020) -
mTORC1 Dependent Regulation of REDD1 Protein Stability
por: Tan, Chia Yee, et al.
Publicado: (2013) -
Pathogenic Role of mTORC1 and mTORC2 in Pulmonary Hypertension
por: Tang, Haiyang, et al.
Publicado: (2018) -
The Hippo kinase LATS2 impairs pancreatic β-cell survival in diabetes through the mTORC1-autophagy axis
por: Yuan, Ting, et al.
Publicado: (2021) -
mTORC1 and mTORC2 in cancer and the tumor microenvironment
por: Kim, Laura C., et al.
Publicado: (2016)